P Jantscheff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Jantscheff

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

European Journal of Immunology|September 29, 2000

Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell responseA Donda, L Mori, A Shamshiev, et al.

Cancer Chemotherapy and Pharmacology|June 8, 2007

A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imagingC Bornmann, R Graeser, N Esser, et al.

Cancer Gene Therapy|June 8, 1999

Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.

Advances in Experimental Medicine and Biology|February 23, 1999

Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.

British Journal of Cancer|November 15, 2000

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.

Pageof 4

Search research articles

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

European Journal of Immunology|September 29, 2000

Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell responseA Donda, L Mori, A Shamshiev, et al.

Cancer Chemotherapy and Pharmacology|June 8, 2007

A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imagingC Bornmann, R Graeser, N Esser, et al.

Cancer Gene Therapy|June 8, 1999

Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.

Advances in Experimental Medicine and Biology|February 23, 1999

Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.

British Journal of Cancer|November 15, 2000

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.

Pageof 4